[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DK387579A - Phenylalkylaminoethylsalicylamid fremgangsmaade til dets fremstilling og farmaceutiske kompositioner indeholdende dette amid - Google Patents

Phenylalkylaminoethylsalicylamid fremgangsmaade til dets fremstilling og farmaceutiske kompositioner indeholdende dette amid

Info

Publication number
DK387579A
DK387579A DK387579A DK387579A DK387579A DK 387579 A DK387579 A DK 387579A DK 387579 A DK387579 A DK 387579A DK 387579 A DK387579 A DK 387579A DK 387579 A DK387579 A DK 387579A
Authority
DK
Denmark
Prior art keywords
acid addition
optical isomer
phenylalkylaminoethylsalicylamide
amide
procedure
Prior art date
Application number
DK387579A
Other languages
English (en)
Inventor
E H Gold
W Chang
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of DK387579A publication Critical patent/DK387579A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/12Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/64Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/65Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Epoxy Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DK387579A 1978-09-20 1979-09-17 Phenylalkylaminoethylsalicylamid fremgangsmaade til dets fremstilling og farmaceutiske kompositioner indeholdende dette amid DK387579A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US94451678A 1978-09-20 1978-09-20

Publications (1)

Publication Number Publication Date
DK387579A true DK387579A (da) 1980-03-21

Family

ID=25481553

Family Applications (1)

Application Number Title Priority Date Filing Date
DK387579A DK387579A (da) 1978-09-20 1979-09-17 Phenylalkylaminoethylsalicylamid fremgangsmaade til dets fremstilling og farmaceutiske kompositioner indeholdende dette amid

Country Status (27)

Country Link
EP (1) EP0009702B1 (da)
JP (3) JPS5555147A (da)
KR (2) KR830000904A (da)
AT (1) ATE351T1 (da)
AU (1) AU528626B2 (da)
CA (1) CA1151211A (da)
CY (1) CY1175A (da)
DD (1) DD150457A5 (da)
DE (1) DE2961263D1 (da)
DK (1) DK387579A (da)
FI (1) FI792884A (da)
GR (1) GR73179B (da)
HK (1) HK13383A (da)
HU (1) HU185523B (da)
IE (1) IE49301B1 (da)
IL (1) IL58258A (da)
KE (1) KE3283A (da)
MY (1) MY8500042A (da)
NO (1) NO149660C (da)
NZ (1) NZ191589A (da)
OA (1) OA06339A (da)
PH (1) PH16794A (da)
PL (1) PL129114B1 (da)
PT (1) PT70191A (da)
SG (1) SG283G (da)
YU (1) YU227379A (da)
ZA (1) ZA794872B (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4658060A (en) * 1982-04-26 1987-04-14 Schering Corporation Preparation of (-)-5-(beta)-1-hydroxy-2-((beta)-1-methyl-3-phenylpropyl)aminoethyl) salicylamide
IT1194406B (it) * 1983-09-27 1988-09-22 Scharper S P A Procedimento per la preparazione di 2-idrossi-5-01-idrossi-2-((4-fenil-2-butil)ammino) etil benzammide
HU190867B (en) * 1984-01-20 1986-11-28 Egyt Gyogyszervegyeszeti Gyar,Hu Process for preparing 2-hydroxy-5-/1-hydroxy-2-/1-methyl-3-phenyl-propyl/-amino/ethyl/-benzamide and pharmaceutically acceptable salts thereof
US4788183A (en) * 1987-11-30 1988-11-29 Schering Corporation Method for treatment of dyslipidemia in humans
US4879233A (en) * 1989-02-10 1989-11-07 Schering Corporation Novel Aspergillus niveus microorganism used for the chiral reduction of carbonyl groups
US6011068A (en) * 1991-08-23 2000-01-04 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5858684A (en) * 1991-08-23 1999-01-12 The Brigham And Women's Hospital, Inc. Method of screening calcium receptor-active molecules
EP1281702B1 (en) * 1991-08-23 2005-12-21 Nps Pharmaceuticals, Inc. Calcium receptor active molecules
US5763569A (en) * 1991-08-23 1998-06-09 The Brigham And Women's Hospital, Inc Calcium receptor-active molecules
US6001884A (en) * 1991-08-23 1999-12-14 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6031003A (en) * 1991-08-23 2000-02-29 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5688938A (en) * 1991-08-23 1997-11-18 The Brigham & Women's Hospital, Inc. Calcium receptor-active molecules
US6313146B1 (en) 1991-08-23 2001-11-06 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5962314A (en) * 1993-02-23 1999-10-05 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
CN1312116C (zh) 1994-10-21 2007-04-25 Nps药物有限公司 钙受体活性化合物
DE69739388D1 (de) 1996-05-01 2009-06-10 Nps Pharma Inc Inorganische am Ionen-Rezeptor aktive Verbindungen
IT1313583B1 (it) 1999-07-30 2002-09-09 Chiesi Farma Spa Derivati 2-amminotetralinici per la terapia del glaucoma.
ES2333266T3 (es) * 2007-02-22 2010-02-18 Indena S.P.A. Procedimiento para la preparacion de sal de acetato del ester metilico de (2r,3s)-3-fenilisoserina.
EP2603215A4 (en) 2010-08-11 2015-08-05 Philadelphia Health & Educatio NEW DOPAMINERGIC D3 RECEPTOR AGONISTS FOR TREATING DYSKINESIA IN PARKINSON'S DISEASE

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1266058A (da) * 1969-07-08 1972-03-08
US4012444A (en) * 1969-07-08 1977-03-15 Allen & Hanburys Limited 5-[1-Hydroxy-2-(1-methyl-3-phenylpropyl)aminoethyl] salicylamide and physiologically acceptable acid addition salts thereof
GB1541932A (en) * 1975-04-17 1979-03-14 Scherico Ltd Diastereoisomers of a phenylalkylaminoethanol derivative

Also Published As

Publication number Publication date
NO149660C (no) 1984-05-30
FI792884A (fi) 1980-03-21
EP0009702B1 (en) 1981-11-04
KE3283A (en) 1983-05-13
DD150457A5 (de) 1981-09-02
HK13383A (en) 1983-04-29
IL58258A0 (en) 1979-12-30
CA1151211A (en) 1983-08-02
JPS5555147A (en) 1980-04-22
IL58258A (en) 1984-01-31
OA06339A (fr) 1981-06-30
YU227379A (en) 1983-06-30
EP0009702A1 (en) 1980-04-16
NZ191589A (en) 1984-03-30
AU5088179A (en) 1980-03-27
KR890001998B1 (ko) 1989-06-07
CY1175A (en) 1983-06-10
MY8500042A (en) 1985-12-31
ATE351T1 (de) 1981-11-15
HU185523B (en) 1985-02-28
SG283G (en) 1983-09-16
GR73179B (da) 1984-02-14
PL129114B1 (en) 1984-03-31
NO792993L (no) 1980-03-21
JPS59108749A (ja) 1984-06-23
JPH0210128B2 (da) 1990-03-06
PL218408A1 (da) 1980-09-08
NO149660B (no) 1984-02-20
PH16794A (en) 1984-02-28
KR840005307A (ko) 1984-11-05
DE2961263D1 (en) 1982-01-14
JPH02167253A (ja) 1990-06-27
AU528626B2 (en) 1983-05-05
ZA794872B (en) 1980-11-26
IE49301B1 (en) 1985-09-18
KR830000904A (ko) 1983-04-28
PT70191A (en) 1979-10-01
IE791770L (en) 1980-03-20

Similar Documents

Publication Publication Date Title
DK387579A (da) Phenylalkylaminoethylsalicylamid fremgangsmaade til dets fremstilling og farmaceutiske kompositioner indeholdende dette amid
DK363689A (da) Purinonderivater og fremgangsmaade til fremstilling deraf
AU683442B2 (en) Aminoacid derivates, medicaments containing these compounds and process for preparing the same
DK0495776T3 (da) Stabiliserende nitrogenoxid/primær amin-komplekser, der er anvendelige som cardiovaskulære midler
ES8609303A1 (es) Un procedimiento para la preparacion de un derivado de acido6-fluor-1,4-dihidro-4-oxo-7-piperazinilquinolin sustituido-3-carboxilico
PH25504A (en) Novel substituted n-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides pharmaceutical composition containing said compound, method of use thereof
MY111055A (en) Pharmaceutical composition and process for the preparation thereof
ATE48001T1 (de) Cephemverbindungen, verfahren zu ihrer herstellung und ihre pharmazeutischen praeparate.
NO164021C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktiv (r,s)-5-amino-hepta-5,6-diensyre, (s)-4-aminohepta-5,6-diensyre og farmasoeytisk akseptable salter derav.
PL326554A1 (en) Derivatives of amine and thiourea and inhibitors of nitrogen oxide synthase
DK0521393T3 (da) Dichlofenac-cholinsalt, fremgangsmåde til fremstilling deraf og farmaceutiske præparater der indeholder det
IL69448A (en) Process for combating phytopathogenic fungi with azolylphenoxy-tetrahydrofuran-2-ylidene methane derivatives
JPS5540601A (en) New 3-(3,4-dihydroxyphenyl)serine derivative
TH1819B (th) การเตรียมอนุพันธ์ 1-แอลคิล-2-อะมิโน-เททราลิน

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment